BioSpace News Archive

The ophthalmic lasers market reached an evaluation of $0.97 bn in 2015. According to a newly released TMR report, the market promises further growth at 4.60% CAGR during 2016-2024, and reach US$1.44 bn in evaluation by 2024 end.

Patient stimulator is a small electronic device worn externally by a patient and affixed to the skin through electrodes.

On an upward growth trajectory, the global microfluidics market will chart a double digit growth over the forecast period of 2017 to 2025.

Respiratory diseases are on a rise and this is leading to growth in demand for medical oxygen concentrations market.

The global medical microbiology testing technologies market is anticipated to experience an intense level of competition among the major players in the market.

A report by Transparency Market Research states that the global gastrointestinal drugs market is expected to witness a robust growth during the tenure of 2016 to 2024.

A recent report by Transparency Market Research states that the global cardiac holter monitor market is projected to grow substantially in the duration of 2016 to 2024.

Fact.MR – A Market Research and Competitive Intelligence Provider: Growing prevalence of cardiovascular diseases across the globe is spurring demand for cardiac ablation technologies.

Novartis today holds an investor event to provide a comprehensive overview of the company’s progress in advancing its industry-leading R&D engine.

UCB announced that it has entered into a global co-development and co-commercialization agreement with Novartis covering UCB0599, a potential first in class, small molecule, alpha-synuclein misfolding inhibitor currently in Phase 2 clinical development, and upon completion of the ongoing Phase 1 program, an opt-in to co-develop UCB7853, an anti-alpha-synuclein antibody, both in Parkinson’s Disease.